Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06787222
PHASE2/PHASE3

Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome

Sponsor: Hasanuddin University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to investigate the effectivity and safety of mild to moderate acne vulgaris therapy using Zingiber officinale 5 % transdermal patch. Researcher will compare both half faces (split face); one side as treatment side where patch is used, and another side as control. Patient will be asked to apply tretinoin 0,025% cream nightly. After applying tretinoin 0,025% on whole face, patient will be asked to apply patch on a pustule on one half face, and no patch will be used on another half face. Total lesion count will be assessed before treatment and 21 days after treatment. Specimen for skin microbiome and interleukin examination will be collected before and 21 days after treatment.

Key Details

Gender

FEMALE

Age Range

15 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2024-11-03

Completion Date

2025-10-31

Last Updated

2025-09-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

tretinoin 0.025% + Z. officinale patch

Material used for patch formulation were 3,15 grams of polyvinyl alcohol, 4,2 grams of polyvinyl pyrrolidone, 12,6 ml distilled water, and 1,05 grams of Z. officinale extract.

DRUG

tretinoin 0.025% cream

no Z. officinale patch applied after tretinoin 0.025% application

Locations (1)

Doctoral Programme, Faculty of Medicine, Hasanuddin University

Makassar, South Sulawesi, Indonesia